Shares of JPMorgan European Growth & Income (LON:JEGI - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as GBX 120.50 ($1.62) and last traded at GBX 120.22 ($1.62), with a volume of 127007 shares changing hands. The stock had previously closed at GBX 119 ($1.60).
JPMorgan European Growth & Income Stock Down 0.4%
The company has a debt-to-equity ratio of 8.40, a quick ratio of 20.49 and a current ratio of 6.69. The stock has a 50 day moving average price of GBX 113.36 and a 200 day moving average price of GBX 107.16. The company has a market cap of £509.05 million, a P/E ratio of 7.25 and a beta of 0.85.
JPMorgan European Growth & Income Company Profile
(
Get Free Report)
Attractive capital growth and a dependable income require a solid foundation
JPMorgan European Growth & Income plc is an innovative investment trust offering the best of both worlds from a single share class structure. The Company allows growth-oriented investors to participate in the attractive long-term growth potential of European stock markets while also aiming to deliver a predictable dividend to income seekers.
Key points:
Expertise - Benefits from portfolio managers with long-standing experience investing in European markets, backed by the full strength and depth of J.P.
Read More
Before you consider JPMorgan European Growth & Income, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JPMorgan European Growth & Income wasn't on the list.
While JPMorgan European Growth & Income currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
